Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Internal Medicine (Tokyo, Japan)|October 8, 2025
Bilateral Cluster Headache-like Attack as a Manifestation of Reversible Cerebral Vasoconstriction Syndrome Following Carotid Artery Stenting: A Case ReportShoji Kikui, Junichi Miyahara, Katsuya Takeuchi, et al.
Brain and Behavior|July 25, 2024
Underrecognition of migraine-related stigmatizing attitudes and social burden: Results of the OVERCOME Japan studyHisaka Igarashi, Mika Komori, Kaname Ueda, et al.
Neurology and Therapy|January 4, 2024
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) StudyEtsuko Awaki, Takao Takeshima, Yasuhiko Matsumori, et al.
Advances in Therapy|September 11, 2022
Potential Unmet Needs in Acute Treatment of Migraine in Japan: Results of the OVERCOME (Japan) StudyTakao Takeshima, Kaname Ueda, Mika Komori, et al.
Cureus|October 6, 2023
Development and Validation of a Japanese-Language Questionnaire to Screen for Tension-Type Headaches and MigrainesKaho Tanobe, Minori Machida, Ryo Motoya, et al.
Neurology and Therapy|December 4, 2021
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) StudyYasuhiko Matsumori, Kaname Ueda, Mika Komori, et al.
Journal of Pain Research|May 24, 2023
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International TrialsKazumasa Saigoh, Takao Takeshima, Masami Nakai, et al.
Rinsho Shinkeigaku = Clinical Neurology|November 21, 2023
[Impact of migraine on family members: an investigation by Impact of Migraine on Partners and Adolescent Children (IMPAC)]Takao Takeshima, Satomi Ooba, Yoshiki Hanaoka, et al.
Psychiatry and Clinical Neurosciences|April 4, 2002
Static stabilometry in patients with migraine and tension-type headache during a headache-free periodKumiko Ishizaki, Nozomi Mori, Takao Takeshima, et al.
Journal of Pain Research|April 27, 2023
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International TrialsKazumasa Saigoh, Takao Takeshima, Masami Nakai, et al.
Pageof 14